| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |